Traveler's diarrhea in the pediatric population: Etiology and impact

Clinical Infectious Diseases

Volumn 41, Issue SUPPL. 11, 2005, Pages

  Mackell, Sheila ^a  

^a Mountain View Pediatrics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; AZITHROMYCIN; BISMUTH SALICYLATE; CIPROFLOXACIN; COTRIMOXAZOLE; FURAZOLIDONE; LOPERAMIDE; NALIDIXIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ACUTE KIDNEY FAILURE; ADOLESCENT; ADULT; ARTHRALGIA; ARTHROPATHY; CAMPYLOBACTER; CLINICAL PRACTICE; COMA; CONFERENCE PAPER; ESCHERICHIA COLI; GIARDIA; HIGH RISK POPULATION; HUMAN; ILEUS; INFANT; LETHARGY; MUSCULOSKELETAL DISEASE; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; SALMONELLA; SCHOOL CHILD; SHIGELLA; TRAVELLER DIARRHEA; TREATMENT INDICATION;

ANTI-BACTERIAL AGENTS; ANTIDIARRHEALS; CHILD; DIARRHEA; HUMANS; RISK FACTORS; TRAVEL;

EID: 28044460799     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/432950     Document Type: Conference Paper

References (35)

1. DuPont HL, Ericsson CD. Prevention and treatment of traveler's diarrhea. N Engl J Med 1993;328:1821-7.
2. Alam NH, Ashraf H. Treatment of infectious diarrhea in children. Paediatr Drugs 2003;5:151-65.
3. World Health Organization. State of the art of new vaccines: research and development. Geneva: World Health Orgnization, 2003. Available at: http://www.who.int/vaccine_research/documents/new_vaccines/en/ index1.html. Accessed: 21 September 2005.
4. Cook SM, Glass RI, LeBaron CW, Ho MS. Global seasonality of rotavirus infections. Bull World Health Organ 1990;68:171-7.
5. Cama RI, Parashar UD, Taylor DN, et al. Enteropathogens and other factors associated with severe disease in children with acute watery diarrhea in Lima, Peru. J Infect Dis 1999;179:1139-44.
6. Ngan PK, Khanh NG, Tuong CV, Quy PP, Anh DN, Thuy HT. Persistent diarrhea in Vietnamese children: a preliminary report. Acta Paediatr 1992;81(Suppl 381):124-6.
7. Youssef M, Shurman A, Bougnoux M, Rawashdeh M, Bretagne S, Strockbine N. Bacterial, viral and parasitic enteric pathogens associated with acute diarrhea in hospitalized children from northern Jordan. FEMS Immunol Med Microbiol 2000;28:257-63.
8. Orndorff GR, Sadjimin T, Simanjuntak CH, et al. Enterotoxigenic Escherichia coli diarrhea in children less than five years of age in central Java. Am J Trop Med Hyg 1996;55:449-51.
9. Albert MJ, Faruque AS, Faruque SM, Sack RB, Mahalanabis D. Case-control study of enteropathogens associated with childhood diarrhea in Dhaka, Bangladesh. J Clin Microbiol 1999;37:3458-64.
10. Vila J, Vargas M, Casals C, et al. Antimicrobial resistance of diarrheagenic Escherichia coli isolated from children under the age of 5 years from Ifakara, Tanzania. Antimicrob Agents Chemother 1999;43: 3022-4.
11. Hoge CW, Echeverria P, Rajah R, et al. Prevalence of Cyclospora species and other enteric pathogens among children less than 5 years of age in Nepal. J Clin Microbiol 1995;33:3058-60.
12. Wong CS, Jelacic S, Habeeb RL, Watkins SL, Tarr PI. The risk of the hemolytic-uremic syndrome after antimicrobial treatment of Escherichia coli O157:H7 infections. N Engl J Med 2000;342:1930-6.
13. Safdar N, Said A, Gangnon RE, Maki DG. Risk of hemolytic uremic syndrome after antimicrobial treatment of Escherichia coli O157: H7 enteritis: a meta-analysis. JAMA 2002;288:996-1001.
14. Lopez EL, Prado-Jimenez V, O'Ryan-Gallardo M, Contrini MM. Shigella and Shiga toxin-producing Escherichia coli causing bloody diarrhea in Latin America. Infect Dis Clin North Am 2000; 14:41-65, viii.
15. Pitzinger B, Steffen R, Tschopp A. Incidence and clinical features of traveler's diarrhea in infants and children. Pediatr Infect Dis J 1991; 10:719-23.
16. Hill DR. Occurrence and self-treatment of diarrhea in a large cohort of Americans traveling to developing countries. Am J Trop Med Hyg 2000;62:585-9.
17. Hirschhorn N. The treatment of acute diarrhea in children: an historical and physiological perspective. Am J Clin Nutr 1980;33:637-63.
18. Brown KH. Diarrhea and malnutrition. J Nutr 2003;133:3285-325.
19. Practice parameter: the management of acute gastroenteritis in young children. American Academy of Pediatrics, Provisional Committee on Quality Improvement, Subcommittee on Acute Gastroenteritis. Pediatrics 1996;97:424-35.
20. Bezerra JA, Stathos TH, Duncan B, Gaines JA, Udall JN. Treatment of infants with acute diarrhea: what's recommended and what's practiced. Pediatrics 1992;90(1 Pt 1):1-4.
21. Bowie MD, Hill ID, Mann MD. Loperamide for treatment of acute diarrhoea in infants and young children: a double-blind placebo-controlled trial. S Afr Med J 1995;85:885-7.
22. Kaplan MA, Prior MJ, McKonly KI, DuPont HL, Temple AR, Nelson EB. A multicenter randomized controlled trial of a liquid loperamide product versus placebo in the treatment of acute diarrhea in children. Clin Pediatr (Phila) 1999;38:579-91.
23. Owens JR, Broadhead R, Hendrickse RG, Jaswal OP, Gangal RN. Loperamide in the treatment of acute gastroenteritis in early childhood: report of a two centre, double-blind, controlled clinical trial. Ann Trop Paediatr 1981;1:135-41.
24. Figueroa-Quintanilla D, Salazar-Lindo E, Sack RB, et al. A controlled trial of bismuth subsalicylate in infants with acute watery diarrheal disease. N Engl J Med 1993;328:1653-8.
25. Johnson PC, DuPont HL, Ericsson CD. Chemoprophylaxis and chemotherapy of travelers' diarrhea in children. Pediatr Infect Dis 1985; 4:620-1.
26. Advice for travelers. Med Lett Drugs Ther 1992;34:41-4.
27. Advice for travelers. Med Lett Drugs Ther 1996;38:17-20.
28. Advice for travelers. Med Lett Drugs Ther 1998;40:47-50.
29. Advice for travelers. Med Lett Drugs Ther 1999;41:39-42.
30. Advice for travelers. Med Lett Drugs Ther 2002;44:33-8.
31. Advice for travelers. Treat Guidel Med Lett 2004;2:33-40.
32. Division of Special Pathogen and Immunology Drug Products, US Food and Drug Administration. Summary of clinical review of studies submitted in response to a pediatric written request: ciprofloxacin. Rockville, MD: US Food and Drug Administration, 2004. Available at: http://www.fda.gov/cder/foi/esum/2004/ 19537_Cipro_BPCA_clinical .pdf. Accessed: 21 September 2005.
33. Chalumeau M, Tonnelier S, D'Athis P, et al. Pediatric Fluoroquinolone Safety Study Investigators. Fluoroquinolone safety in pediatric patients: a prospective, multicenter, comparative cohort study in France. Pediatrics 2003;111(6 Pt 1):e714-9.
34. Yee CL, Duffy C, Gerbino PG, Stryker S, Noel GJ. Tendon or joint disorders in children after treatment with fluoroquinolones or azithromycin. Pediatr Infect Dis J 2002;21:525-9.
35. Rakita RM, Jacques-Palaz K, Murray BE. Intracellular activity of azithromycin against bacterial enteric pathogens. Antimicrob Agents Chemother 1994;38:1915-21.